Type 2 Diabetes Market To Grow With Advances in Treatment And Care
22 Jan, 2025
The global type 2 diabetes market comprises products utilized for the management and treatment of type 2 diabetes such as insulin injections, oral hypoglycemic drugs, blood glucose monitoring devices, and others. Type 2 diabetes is a chronic condition that arises when the pancreas does not produce enough insulin or the body cannot effectively use the insulin it produces. It requires long-term medical attention and health care to manage the disease and prevent acute complications. The market offers various drug classes such as sulfonylureas, biguanides, and thiazolidinediones which help reduce blood glucose levels and the risk of complications. Similarly, insulin delivery devices are used for monitoring glucose levels and administering insulin when required.
The Global Type 2 Diabetes Market is estimated to be valued at US$ 62.87 billion in 2024 and is expected to exhibit a CAGR of 7.7% over the forecast period 2024–2028.
Key Takeaways Key players operating in the Type 2 Diabetes market are Novo Nordisk, Sanofi, Eli Lilly and Company, AstraZeneca, Boehringer Ingelheim.
The increasing prevalence of diabetes, growing obesity rates,and rising geriatric population are expected to present significant Type 2 Diabetes Market Growth opportunities for players in the market.
Advances in diabetes management technologies including continuous glucose monitoring systems, smart insulin pens and patch pumps are enhancing patient outcomes and experience in diabetes care management.
Market Drivers The rising number of individuals with sedentary lifestyles and unhealthy dietary habits has significantly contributed to the increasing incidence of obesity and type 2 diabetes. According to WHO, the prevalence of diabetes was approximately 422 million in 2014 and has increased to around 514 million as of 2019 globally. This accelerating diabetes burden worldwide is a major factor driving the demand for diabetes management and treatment. Moreover, favorable reimbursements and increasing healthcare expenditures in major markets will also support the growth of the type 2 diabetes market over the forecast period.
Current Challenges in Type 2 Diabetes Market Managing type 2 diabetes is a complex process that requires maintaining strict glucose levels through medication, diet and lifestyle changes. Non-adherence to treatment is a major challenge faced by patients. Factors like complex regimens, cost of medication and monitoring devices, side effects associated with drugs often lead to poor medication adherence and glycemic control among patients. Lack of awareness about the disease is another issue, with many patients not realizing the severity and risks of uncontrolled type 2 diabetes. Behavioral and psychosocial barriers also negatively impact self-management.
\Changing lifestyle habits as recommended is difficult for most. Insufficient screening further delays diagnosis, aggravating health complications. Healthcare systems also face resource constraints in providing affordable treatment access to all patients. Development of more effective and user-friendly treatment solutions remains a priority to address the growing global diabetes burden.
SWOT Analysis Strength: Rising R&D investments by key players to develop innovative products like new drug classes, superior devices are helping expand treatment options. Weakness: High costs involved with current standard of care regimens and lack of affordable access in low and middle-income countries. Opportunity: Growing geriatric population susceptible to diabetes creates scope for market expansion. Threats: Risk of developing costly complications if disease remains uncontrolled over long term posing treatment challenges and negatively impacting outcomes.
The United States currently accounts for the largest share in the type 2 diabetes market, due to factors like the high diabetes prevalence rate, raised awareness levels, and well-established healthcare infrastructure in the country. China stands as the second largest regional market and is also witnessing strong growth, backed by rapid economic development, increasing urbanization, shift towards sedentary lifestyles and adoption of disease management programs by the government. India with its huge diabetic patient pool indicates high market potential. Middle East and Latin American countries are also emerging as lucrative geographical areas.
Among regions, Asia Pacific is likely to witness the fastest growth in the type 2 diabetes market during the forecast period, rising at a CAGR of over 8%. This can be attributed to growing diabetic burden correlated with lifestyle changes, expanding geriatric demographics and improving access to diagnosis and treatment in developing Asian countries. Rising medical expenditures of a rapidly developing economies in the region will further aid market expansion.
Write a comment ...